Additive Dose Response Models: Explicit Formulations and the Loewe Additivity Consistency Condition
Abstract
High-throughput techniques allow for massive screening of drug combinations. To find combinations that exhibit an interaction effect, one filters for promising compound combinations by comparing to a response without interaction. A common principle for no interaction is Loewe Additivity which is based on the assumption that no compound interacts with itself and that doses of both compounds for a given effect are equivalent. For the model to be consistent, the doses of both compounds have to be proportional. We call this restriction the Loewe Additivity Consistency Condition (LACC). We derive explicit and implicit null reference models from the Loewe Additivity principle that are equivalent when the LACC holds. Of these two formulations, the implicit formulation is the known General Isobole Equation [1], whereas the explicit one is the novel contribution. The LACC is violated in a significant number of cases. In this scenario the models make different predictions. We analyze two data sets of drug screening that are non-interactive [2, 3] and show that the LACC is mostly violated and Loewe Additivity not defined. Further, we compare the measurements of the non-interactive cases of both data sets to the theoretical null reference models in terms of bias and mean squared error. We demonstrate that the explicit formulation of the null reference model leads to smaller mean squared errors than the implicit one and is much faster to compute.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Additive Dose Response Models: Defining Synergy
S. Lederer, T. Dijkstra, T. Heskes·bioRxiv·Jul 31, 2019
- A reference model for the combination of an arbitrary number of drugs: A generalization of the Bliss independence model
W. De Mulder, M. Kuiper, A. Flobak·bioRxiv·May 7, 2019
- The null additivity of multi-drug combinations
Dor Russ, Roy Kishony·Nature MicrobiologyPeer-reviewed·Oct 3, 2018
- Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible
Mark Sinzger-D’Angelo, Jakob Vanhoefer, … Jan Hasenauer·Scientific ReportsPeer-reviewed·Feb 28, 2019
- SiCoDEA: a simple, fast and complete app for analyzing the effect of individual drugs and their combinations
Giulio Spinozzi, Valentina Tini, … Maria Paola Martelli·BiomoleculesPeer-reviewed·Jun 28, 2022
- Antimicrobial Combination Effects at Sub-inhibitory Doses do not Reliably Predict Effects at Inhibitory Concentrations
Malte Muetter, Daniel C. Angst, … Sebastian Bonhoeffer·bioRxiv·Sep 1, 2026